BTIG Research initiated coverage on TScan Therapeutics with a new price target
$TCRX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
BTIG Research initiated coverage of TScan Therapeutics with a rating of Buy and set a new price target of $12.00